ERBB2 and breast cancer: In this investigation, five‐year, low‐risk Tyrer‐Cuzick gene expression profile, expected to be negatively correlated with risk, was associated with certain, more aggressive breast cancer subtypes, including basal‐like and HER2‐enriched subtypes.